Optimer® delivery vehicles enable targeted delivery of diverse payloads to challenging cell types
The advent of oligonucleotide therapeutics has given rise to novel drug development strategies. Oligonucleotide ligands can operate as both independent therapeutic modalities and as delivery vehicles for diverse payloads…